Scandinavian Biopharma announces the last follow up visit in the phase IIB clinical trial with ETVAX® in Finnish travellers to Benin
In record time Scandinavian Biopharma completed a phase IIB randomized, double-blind, placebo-controlled trial in Finnish travellers going to Benin in West Africa. All participants have now been enrolled and the last travellers left Benin in March 2019. The last follow up visit was conducted just before Easter. In total 743 healthy travellers, between the ages […]